The observed radioresistance of human glioblastoma multiforme (GBM) poses a major challenge, which, if overcome, may lead to significant advances in the management of this patient population. There is accumulating evidence from correlative studies that Survivin expression is associated with increased malignant potential of human gliomas. The purpose of this study was to investigate whether Survivin plays a direct role in mediating radiation resistance in primary human glioma cell lines, and, if so, investigating the underlying mechanisms. Our panel of GBM cell lines included two that were relatively radiation resistant (GM20 and GM21) and two that were more radiation sensitive (GM22 and GM23), which demonstrated differential levels of Survivin expression between the two groups. Through the use of adenoviral vectors containing either dominant-negative (pAd-S(T34A)) or wild-type Suvrivin (pAd-S(WT)), we were able to inactivate or overexpress Survivin, respectively. Our findings suggest that Survivin plays a critical role in mediating radiation resistance in primary GBM cells, in part through suppression of apoptotic cell death via a caspase-independent manner. We have identified novel mechanisms by which Survivin may enhance tumor cell survival upon radiation exposure such as regulation of double-strand DNA break repair and tumor cell metabolism, which were most evident in the radiation-resistant cell lines. These differences in Survivin function both in radiation-resistant vs radiation-sensitive cell lines and in the presence vs absence of radiation exposure warrant further investigation and highlight potentially important mechanisms of radiation resistance in these tumors.
Introduction
Human gliomas are among the most aggressive tumors, with no curative therapies currently available. Molecular and genetic mechanisms that serve to enhance the malignant potential of these tumors are becoming better understood (Maher et al., 2001) . Patients with glioblastoma multiforme (GBM), a WHO Grade IV/IV glioma, are routinely managed by surgery followed by adjuvant radiation and chemotherapy. Despite such aggressive treatment approaches, median survival times remain under 1 year in most series (Walker et al., 1978 (Walker et al., , 1980 Davis et al., 1999) . Identifying the molecular and genetic mechanisms underlying treatment resistance represents an important first step for the development of more effective therapies against GBMs.
Survivin expression has been associated with adverse clinical outcome and enhanced malignant potential of gliomas (Chakravarti et al., 2002; Sasaki et al., 2002; Kajiwara et al., 2003; Katoh et al., 2003) . Survivin is a 16.5 kDa member of the inhibitor of apoptosis (IAP) family of proteins, which has been found to be expressed in the G2/M phases of the cell cycle almost exclusively in tumor cells, but absent in most normal adult differentiated tissues (Ambrosini et al., 1997 (Ambrosini et al., , 1998 Kobayashi et al., 1999; Li and Altieri, 1999; Skoufias et al., 2000; Wright et al., 2000; Grossman et al., 2001; Jiang et al., 2001; Fortugno et al., 2002a) . It is thought that Survivin enhances survival of tumor cells primarily through suppression of apoptotis-related cell death perhaps via direct inhibition of caspase-related proteins (Conway et al., 2000; Wright et al., 2000; Shin et al., 2001) . Whether Survivin plays a direct role in promoting radiation resistance of GBMs and, if so, the precise mechanisms involved are outstanding issues. We report here that Survivin does, indeed, appear to play a mechanistic role in enhancing cell survival upon radiation exposure in a manner that appears to be independent of its known caspase-mediated functions.
Results

Survivin expression levels in radiation-resistant vs radiation-sensitive primary GBM cell lines
Primary cell lines were established from four GBM tumor specimens as described above. As Figure 1a demonstrates, GM20 and GM21 were found to be relatively radiation resistant compared to GM22 and GM23, as determined by clonogenic survival assays. Survivin expression levels were found to be higher in GM20 and GM21 compared with GM22 and GM23. Further, after radiation exposure, levels of phospho-Survivin were found to increase in all four primary GBM cell lines (Figure 1b) , indicating that radiation can lead to more stable (phosphorylated) isoforms of Survivin. Although Survivin expression was most evident in the G2/M phases of the cell cycle under physiologic conditions (Figure 1c) , after radiation exposure, Survivin expression was evident throughout all phases of the cell cycle in the more radioresistant GM 20 and GM21 cell lines (Figure 1d ).
Antagonism of Survivin enhances radiation response
The four primary GBM cell lines were treated with adenoviral vectors containing either dominant-negative (Ad-S(T34A)) or with wild-type (Ad-S(WT)) Survivin to either inactivate or further activate Survivin function, respectively, in these cells. It is apparent that in all four cell lines, cells treated by Ad-S(T34A) demonstrated increased sensitivity to radiation compared to untreated cells (Po0.0001, Figures 2a-d) . In contrast, cells overexpressing wild-type Survivin through treatment with Ad-S(WT) demonstrated increased resistance to radiation compared to untreated cells (Po0.0001, Figures  2a-d) . Interestingly, when normal fetal astrocytes were infected with either Ad-S(T34A) or Ad-S(WT), there were no appreciable shifts in the clonogenic survival curves (data not shown), indicating that Survivin is better able to protect tumor vs normal cells from radiation-induced cell death. In vivo confirmation of these findings were made by irradiating Survivinexpressing U87 xenografts. These xenografts were either treated by an empty-vector adenovirus (Ad(Empty)) or Ad-S(T34A) in the presence of radiation. Figure 3a demonstrates that there were significantly fewer viable cells in the tumors treated by Ad-S(T34A) þ RT than the Ad(Empty) þ RT group. This translated into significantly decreased TCD 50 values for the Ad-S(T34A)-treated tumors than the Ad(Empty)-treated tumors (Figure 3b ), providing further evidence of the role of Survivin in mediating radioresistance in GBMs. Cell cycle arrest was induced in cells using mimosine (at G1), thymidine (at S), and nocodazole (at G2/M) followed by Western analysis demonstrating Survivin expression only in G2/M phases of the cell cycle. (d) Same series of experiments as (c), but after irradiation, demonstrating pan-cell cycle expression of Survivin in the radioresistant GM20 and GM21 cell lines, but only in G/M in the more radiosensitive GM22 and GM23 cell lines Role of Survivin in enhancing radiation resistance A Chakravarti et al Survivin-mediated radiation resistance appears to be independent of caspase activity We next investigated whether Survivin's ability to enhance survival upon radiation exposure is secondary Figure 2 (a-d) Respective cell lines expressing the nonphosphorylatable mutant of Survivin (T34A) tend to have enhanced radiation sensitivities compared to those cell lines expressing endogenous levels of wild-type Survivin, especially at higher radiation doses. Cell lines forced to overexpress wild-type Survivin via infection with pAd-S(WT) were found to have generally increased levels of radioresistance, with the exception of the GM20 cell line, compared to those cell lines expressing endogenous levels of wild-type Survivin and those expressing the dominantnegative form (T34A) f) . Upon treatment with Ad-S(T34A), there was increased apoptotic activity that corresponded to this time frame after irradiation which was increased compared to corresponding cells treated by Ad(Empty). However, time-course measurements of apoptosis revealed using Annexin V-FITC and Nucleosome ELISA assays additional peaks in apoptotic activity at 18-30 h after irradiation in the Ad-S(T34A)-treated cells. Interestingly, these additional peaks were not detected using the cleaved caspase 3 activation assay nor with assays that detect activation of other caspase members. This suggests that Survivin may suppress radiation-induced apoptosis, at least in part through caspase-independent mechanisms in primary GBM cells.
To further examine whether Survivin does, indeed, enhance survival in these primary GBM cells in a caspase-independent manner, further experiments were conducted in which clonogenic survival of Ad-S(T34A)-expressing cell lines were assayed either in the presence or absence of the pan-caspase inhibitor (VAD-CHO) (Figures 5a-c) . Interestingly, pan-caspase inhibition was unable to shift the clonogenic survival curve 'upward' compared to the untreated Ad-S(T34A)-expressing cells, which would be the expected outcome if Survivin were to mediate radiation resistance exclusively through suppression of caspase-mediated apoptosis. As an alternative to caspase-mediated pathways, it was further investigated whether AIF (apoptosis-inducing factor) (Cande et al., 2002) was directly involved in radiationinduced apoptosis upon Survivin inactivation. No cellular redistribution of AIF could be detected upon Survivin inactivation in any of the cell lines, indicating that Survivin may promote radioresistance in GBM cells in both a caspase-and AIF-independent mechanisms (data not shown).
We next investigated whether Survivin was able to enhance survival in these cell lines in the absence of radiation and, if so, identify whether this may be related to its ability to suppress caspase-mediated apoptosis. It was determined that there was a significant increase in baseline apoptosis levels in these cell lines treated by Ad-S(T34A) compared to cells treated by Ad(Empty) controls using all three assays (Po0.0001). Further, there was a significant decrease in apoptosis levels in cells treated by Ad-S(WT) (Po0.0001). This translated into decreased viability of Ad-S(T34A)-expressing cells and increased viability of Ad-S(WT)-expressing cells compared to empty vector controls (Po0.0001). Treatment with both DEVD-FMK and VAD-CHO were able to increase viability of Ad-S(T34A)-treated cells (Po0.0001), indicating that Survivin's ability to increase survival in primary GBM cells lines under normal physiologic conditions, unlike under postirradiation conditions, appears to be more dependent on its ability to suppress caspase-mediated apoptosis.
Survivin's role in enhancing double-strand DNA repair in primary GBM cells
In consideration of these findings, highly suggestive of caspase-independent functions of Survivin in mediating radiation resistance, we proceeded to investigate alternative mechanisms by which Survivin can enhance clonogenic survival in radiation-treated primary GBM cells. Subcellular fractionation experiments were conducted to determine the primary location of Survivin expression. In the absence of irradiation, Survivin expression is located predominantly in the cytoplasm. However, following irradiation, there appears to be increased levels of intranuclear Survivin in the radiationresistant cell lines GM20 and GM21 (Figure 6a, b) , as determined by subcellular fractionation and immunofluorescence experiments. In contrast, the more radiation-sensitive cell lines GM22 and GM23 failed to demonstrate elevated intranuclear levels of Survivin following irradiation. Immunofluorescence (IF) experiments appeared to confirm increased intranuclear level of Survivin in GM20 (Figure 6b ) cell line, respectively.
In light of the observation that radiation-resistant GBM cell lines demonstrated increased intranuclear Survivin levels, unlike their more radiation-sensitive counterparts, we further investigated whether differences and shifts in cellular compartmentalization of Survivin was of any mechanistic significance. As the degree of double-strand DNA damage has been found to be associated with cell death upon radiation exposure, we investigated whether Survivin plays a role in double-strand break repair in primary GBM cells upon irradiation. Cell lines were treated with either Ad(Empty), Ad-S(T34A), or Ad-(WT), followed by irradiation (2 Gy). Comet assays were performed under neutral elution conditions to determine the degree of double-strand DNA damage at various time points after irradiation. The tail length of migrating DNA on the electrophoretic gel is normally indicative of the degree of double-strand DNA damage under such conditions and, hence, an indicator of the degree of double-strand DNA break repair. Figure 7a illustrates a significantly greater degree of double-strand DNA damage (and, hence, significantly less double-strand DNA repair) in GM20 cells expressing S-T34A compared to the control cells infected with empty vector. Likewise, there appeared to be significantly less double-strand DNA damage in GM20 cells overexpressing wild-type Survivin via infection with pAd-S(WT), indicating increased double-strand DNA repair capacity. Figure 7b illustrates the median Comet tail lengths for both radioresistant GM20 and GM21 cell lines, which likewise implicate a role for Survivin in double-strand DNA repair upon radiation exposure for these radioresistant cell lines. For the more radiosensitive GM22 and GM23 cell lines, the length of the Comet tails appeared to be unaltered either by treatment with Ad-S(T34A) or Ad-S(WT) (Figures 7c and d ). Survivin's role in mediating double-strand DNA break repair was confirmed by using Survivin antisense oligonucleotides against Survivin mRNA, in GBM cell lines, with sense and scrambled sequences serving as controls (data not shown). These observations suggest that Survivin's double-strand DNA repair function may be critical in the development of a radioresistant phenotype in GBMs.
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Survivin's role in increasing intracellular ATP levels upon radiation exposure
Enhanced and/or persistant tumor cell metabolism is often a hallmark of radiation-resistanct GBMs (Mangiardi, 2001 ). Therefore, we further investigated whether Survivin may play a role in persistent or elevated tumor cell metabolism following RT by measuring intracellular ATP levels. Figure 8a demonstrates that the observed intracellular accumulation of ATP following radiation appears to be tightly regulated by Survivin in radioresistant GM20 cells. Inhibition of glycolytically produced ATP by 2-deoxyglucose (2-DG) to a greater extent than inhibition of oxidatively produced ATP by 3-nitroproprionic acid (3-NPA) appears to abrogate radiation-mediated increases in intracellular ATP levels observed after introduction of Ad-S(WT) into GM20 cells, suggesting that Survivin appears to enhance ATP production in response to RT somewhat more through glycolytic, than oxidative, pathways in glioma cells. Figure 8b shows that the observed increase in clonogenic survival seen in the GM20 cell line upon introduction of Ad-S(WT) can be antagonized by inhibition of glycolytically produced ATP by 2-DG and of oxidatively produced ATP by 3-NPA. In contrast, in Survivin's ability to increase intracellular ATP levels appears more limited in the more radiosensitive GM22 cell line (Figure 8c ). Likewise, suppression of ATP production in GM22 did not appreciably affect clonogenic survival in the radiosensitive GM22 cell line (Figure 8d ). Therefore, Survivin's ability to enhance clonogenic surivival after RT in glioma cells through enhanced production of both glycolytically generated and oxidatively generated ATP appears to be limited to the more radiation-resistant GBM cell lines. These findings provide further evidence that Survivin's ability to enhance both double-strand DNA break repair and tumor cell metabolism, in addition to its better characterized antiapoptotic function, may be critical to its ability to produce a radioresistant phenotype in GBM.
Dynamic role of survivin in acquired radioresistance in GBM As GBMs are normally treated by multifraction radiation treatments (B30), the role of Survivin in mediating resistance to fractionated radiation treatments was further examined. As demonstrated in Figure 8e , GM22 cells surviving 2 Gy of radiation were considerably more resistant to additional radiation treatments. It was also apparent that expression levels of Survivin were significantly more elevated at baseline in clonogens, surviving the first dose of radiation compared to unirradiated cells (Figure 8f ). Comet assay findings suggested increased ability of these radiationresistant clones to repair double-strand DNA damage compared to their unirradiated counterparts (Figure 8g ). It was also determined that inhibition of Survivin by Ad-S(T34A) was associated with decreased doublestrand DNA repair capacity in these otherwise resistant clones. It was also apparent that the increased levels of intracellular ATP in previously irradiated GM22 cells upon RT exposure were in a large measure regulated by Survivin (Figure 8h ). Inactivation of Survivin with Ad-S(T34A) appeared to dramatically enhance the radiation sensitivities of these otherwise radiation-resistant clones (Figure 8e ).
Discussion
Survivin has emerged as an attractive therapeutic target and potentially important prognostic marker in many tumor types, including human gliomas (Ambrosini et al., 1997; Adida et al., 1998 Adida et al., , 2000 Kawasaki et al., 1998; Lu et al., 1998; Monzo et al., 1999; Asanuma et al., 2000; Islam et al., 2000; Olie et al., 2000; Tanaka et al., 2000; Grossman et al., 2001; Smith et al., 2001; Merlo, 2003) . There have been four recent studies demonstrating that Survivin expression is associated with glioma progression from low-to high grade (Tan et al., 1993; Chakravarti et al., 2002; Sasaki et al., 2002; Kajiwara et al., 2003; Katoh et al., 2003) . Further, these studies demonstrate that Survivin expression is a marker for adverse outcome in glioma patients. Given such strong evidence implicating Survivin's role in enhancing the malignant phenotype of gliomas, in this study we investigated whether Survivin plays a direct role in mediating radiation resistance and, if so, elucidate possible underlying mechanisms, as radiation resistance is known to have multifactorial etiologies. As radiation has a demonstrated role in significantly improving clinical outcomes of malignant glioma patients, it is quite possible that overcoming radiation resistance may be a promising strategy in improving outcome for these patients.
In our panel of cell lines, Survivin expression appeared to be a marker for radiation resistance, with strongest expression in radiation-resistant glioma phenotypes. Further, radiation appeared to increase levels of phospho-Survivin, which is a more stable Survivin isoform than its unphosphorylated counterpart (Altieri, 2003) . Direct inhibition of Survivin using the pAd-T34(A) dominant-negative construct reduced clonogenic survivals of our entire panel of primary GBM cell lines, suggesting therapeutic benefit of Survivin antagonism Figure 4 (a-c) Time-course measurements of apoptosis for GM20 cells measured using Annexin V (a), cleaved caspase 3 activation (b), or nucleosome ELISA (c) assays. As detected through the Annexin V assay, (a) indicates a bimodal apoptotic peak upon radiation exposure in GM20 cells treated by pAd-S(T34A), a single apoptotic peak in GM20 cells treated by pAd(empty), and no dectectable apoptotic peaks in untreated control GM20 cells. The first apoptotic peak detected by the Annexin V assay appears to be confirmed by the cleaved caspase 3 activation assay (b) and nucleosome ELISA assay (not shown). However, the second apoptotic peak is not apparent on the cleaved caspase 3 assay (b), although it appears to be confirmed in the nucleosome ELISA (c), raising the possibility of Survivin suppressing cell death via a caspase-independent mechanism upon radiation exposure in GBM cells. These findings were confirmed in GM22 cells (d-f) Role of Survivin in enhancing radiation resistance A Chakravarti et al even in cells with weak Survivin expression. One common denominator was that Survivin suppressed radiation-induced apoptosis across our entire panel of GBM cell lines, albeit apparently through a caspaseindependent mechanism. It was further revealing to find that under physiologic conditions, suppression of caspase-mediated apoptosis appears to be the primary mechanism by which Survivin enhances survival of this panel of GBM cell lines, further highlighting the unique roles of Survivin in the presence of radiation. We found that there was no significant relationship between TP53 mutation status with survivin expression, radioresistance, DNA repair, and ATP metbolism in GBM cell lines.
There appeared to be important differences, however, in the radiation-resistant and radiation-sensitive GBM cell lines. In the more radiation-resistant cell lines, radiation induced a pan-cell cycle expression of Survivin, unlike their radiosensitive counterparts, where Survivin was expressed primarily in the G2/M phases of the cell cycle. Further, there appeared to be differences in the mechanisms by which Survivin contributed to radioresistance in the sensitive vs resistant cell lines. Radiation appeared to cause a shift Figure 5 (a) As in previous experiments, treatment of GM20 cells with pAd-S(T34A) enhances the radiosensitivity of these cells, compared to empty-vector controls. However, treatment with the pan-caspase inhibitor VAD-CHO was unable to increase cell survival in pAd-S(T34A)-treated cells indicating that Survivin may normally enhance cellular survival in GBM cells through a caspaseindependent mechanism. These findings were confirmed in GM21 (b), GM22 (c) cells Figure 6 (a) Using subcellular fractionation and Western analysis, in the absence of radiation, Survivin is located primarily in the cytoplasm in all four primary GBM cell lines. Upon radiation exposure, there appears to be a shift in Survivin expression from the cytoplasm to the nucleus in the radioresistant GM20 and GM21 cell lines, but not in the more radiosensitive GM22 and GM23 cell lines. Using immunofluorescence, increased intranuclear Survivin was verified in GM20 (b) cell lines, respectively, upon radiation exposure
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A Chakravarti et al in cellular compartmentalization of Survivin from the cytoplasm to the nucleus, exclusively in the radioresistant GBM cells. This appeared to be associated with enhanced double-strand DNA repair capabilities of the radioresistant cells, compared to their more radiosensitive counterparts. It remains unclear whether Survivin plays a direct or indirect role in the DNA repair process; however, it is apparent that disrupting Survivin disrupts double-strand DNA repair capabilities of radiation-resistant GBM cells, thereby sensitizing these cells to radiation-induced cell death. It has been previously demonstrated that energy depletion plays an important role in caspase-independent neuronal cell death (Lang-Rollin et al., 2003) . The present study also suggests that Survivin contributes to a hypermetabolic state in GBMs upon radiation expsosure, contributing to their radioresistant phenotypes.
Indeed, further investigation should be undertaken to determine the precise role of Survivin in the pathogenesis of human gliomas. The present model of glioblastoma involves characteristic genetic mutations, whereby these lesions can arise either from lower grade tumors (e.g. linear progressive GBMs) or in the absence of preexisting lesions (e.g. de novo GBMs). As the biological underpinnings of such phenomena as radioresistance are often multi-rather than unifaceted, identifying such coexisting pathways can only enhance our understanding of the underlying mechanisms by which Survivin enhances double-strand DNA break repair and tumor cell metabolism. In addition to enhancing our biological perspective, such an understanding would also serve to further identify the role of anti-Survivin targeting strategies in human glioblastomas, a disease for which there are no curative options currently available. In conclusion, the findings of this study challenge conventional wisdom that Survivin enhances survival of tumor cells in a unidimensional manner, for example, exclusively through suppression of caspase-mediated apoptosis. In the presence of radiation, novel functions of Survivin appear to emerge such as enhancement of double-strand DNA break repair and enhancement of tumor cell metabolism, thereby suppressing radiationinduced cell death. These novel functions of Survivin deserve further study to help uncover the mechanisms of treatment resistance in these tumors.
Materials and methods
Cell culture
The four cell lines used in this study (GM20, GM21, GM22, and GM23) were established in culture from human glioblastoma tumors, using techniques as previously described (Westphal et al., 1990) under an Institutional Review Board (IRB)-approved protocol. Briefly, the GBM tissues were obtained during open resection, mechanically dissociated, and the dispersed cells and fragments were cultured and passaged as described. Adenoviral Survivin constructs, including Adeno-Survivin-T34A (dominant-negative form of Survivin) and Adeno-Survivin-WT, were provided courtesy of Dr Dario Altieri.
Western blot analysis
Lysates were generated by placing these cells in RIPA lysis buffer (for Suvivin and AIF) or Chaps Lysis buffer (for cleaved caspase 3). Bradford assays were performed to determine total protein concentrations, which were normalized to 1 mg/ml for all samples. Samples were then prepared in sample buffer and heated to 951C for 5 min. These samples were then run on 16% polyacrylamide gels for Survivin. Protein lysates (15 ml) in sample buffer from each tissue were loaded within each well. Gels were run at constant current (40 mA) for 3-4 h for maximum separation. Wet transfer was performed for 4 h at constant voltage (40 V) using polyvinylidene difluoride membrane presoaked in methanol. The membrane was blocked in 5% milk in 0.2% TBST. The membrane was then washed in 0.2% TBST Â 3 for 15 min each. The membranes were then incubated overnight with primary antibodies directed at either Survivin (Novus biological, Littleton, CO, USA) or apoptosis-inhibiting factor (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) or cleaved caspase 3 (Cell Signaling, Cambridge, MA, USA). Subsequently, the membranes were washed in 0.2% TBST Â 3 for 15 min each. The membrane was then incubated with secondary antibody for 45 min. Chemiluminescent (Bio-Rad, Hercules, CA, USA) detection was then used to detect expression of Survivin, AIF, and cleaved caspase 3, respectively. For each gel, positive and negative controls were loaded for Survivin, AIF, and cleaved caspase 3, respectively. Actin levels served as internal loading controls. Subcellular fractionation experiments were performed as previously described (Fortugno et al., 2002b) .
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 30 min, permeabilized by addition of cold (À201C) methanol for 15 min, and soaked in D-PBS containing 10% goat serum for more than 1 h. Cells were than incubated with anti-survivin pAb (Novus Biologicals, 1 : 1000) diluted in D-PBS (containing 10% goat serum) overnight at 41C. Cells were washed in D-PBS, and then incubated with Alexa Fluor 488 goat anti-rabbit IgG (Molecular Probes, Eugene, OR, USA, 1 : 1000) diluted in D-PBS (containing 10% goat serum) for 1 h. Following three washes with D-PBS, cells were incubated in 0.1 mg/ml PI for 10 min, after which a glass coverslip was mounted on the cells in Fluorsave reagent (Calbiochem, San Diego, CA, USA). Fluorescent images were visualized through a fluorescent microscope, Nikon Eclipse E600.
Adenoviral preparation
The adenoviruses used for this study were provided with the kind generosity of Dr Dario Altieri and are described fully elsewhere (Mesri et al., 2001) . The pAd-S(T34A) constructs contain a mutant Thr 34 -Ala mutant Survivin cDNA, which has been previously demonstrated to function as a dominantnegative construct. The pAd-S(WT) vector contains the wildtype Survivin cDNA, which can be used to overexpress wildtype Survivin; the pAd(empty) contain an empty vector and was used as controls for several experiments. Viral supernatant (1 ml) was used to infect 3 Â 10 6 -5 Â 10 6 293 cells. Viruses were harvested at 2-3 day intervals, which was repeated 3-5 times with a total of 5 Â 10 8 packaging cells, and viral particles were purified by CsCl banding. Green fluorescence forming units (GFU) were estimated by serial dilution of the viral stock in transduced 293 cells.
Cell cycle synchronization
The primary GBM cells were treated with 400 mM mimosone (to arrest cells in G1), 2 mM thymidine (to arrest cells in S phase), or 0.4 mg/ml nocodazole (to arrest cells in G2/M) (all from Sigma, St Louis, MO, USA) for 16 h at 371C or were arrested at the G1/S boundary by sequential culture with 2 mM thymidine and 400 mM mimosine. 
Clonogenic survival assay
Clonogenic survival assays were performed as previously described. In brief, plating efficiencies of all four primary cell lines were initially determined. Survival fraction at each radiation dose level was calculated, with plating efficiency taken into consideration. Colonies were defined as greater than 50 cells. Each set of experiments was performed in duplicate.
Xenograft tumor control dose 50 assay U87 tumor cells were injected into the flanks of nude mice and allowed to reach 0.5 cm in size. These U87 xenografts were injected either with Ad-S(T34A) or Ad-S(WT) or with Ad(Empty) controls, and then irradiated with varying radiation doses. For local administration of pAd vectors, tumor masses were injected in three sites with pAd-S(T34A), pAd-S(WT), or pAd(empty) at 5 Â 10 8 GFU/site of injection (50 ml). The radiation dose needed to eradicate 50% of these tumors was defined as the TCD 50 for a given treatment arm in this series of experiments.
Apoptosis Assays
Apoptosis was assayed using four different methods:
Detection of membrane externalization of phosphatidylserine with Annexin V-FITC conjugate (Caltag, Burlingame, CA, USA)
Cells were harvested at various intervals after treatment and resuspended in PBS solution. Both adherent and floating cells were harvested at various intervals after treatment and resuspended in PBS solution. Propidium iodide was added to a final concentration of 1 mg/ml. This was analysed using blue light excitation, and green fluorescence of FITC was measured at 530720 nm, and red fluorescence was measured at 4600 nm.
Caspase Activity Assay (Oncogene, Cambridge, MA, USA) This assay detects activated caspases in situ in living cells using a caspase inhibitor (VAD-FMK) conjugated to a sulfo-rhodamine as the fluorescent in situ marker. Red-VAD-FMK is cell permeable and irreversibly binds to activated caspases in apoptotic cells. The red fluorescence label allows for direct detection of activated caspases in apoptotic cells by fluorescence plate reader. In total, 1 Â 10 6 cells/ml were irradiated. Then, 1 ml of Red-VAD-FMK was incubated with 300 ml of this cell suspension for 1 h in a 371C incubator with 5% CO 2 . The cells were then centrifuged for 5 min at 3000 r.p.m. After supernatant was removed, cells were resuspended in 0.5 ml of wash buffer and centrifuged again Â 2. The cells were then resuspended in 100 ml wash buffer and transferred to each well of the microtiter plate. The fluorescence intensity was measured at excitation 540 nm and emission at 570 nm.
Cleaved Caspase III detection using Western Analysis The was performed as described above.
Quantitative Analysis of DNA fragmentation using nucleosome ELISA This technique allows for the quantitation of apoptotic cells by DNA-affinity-mediated capture of free nucleosomes followed by anti-histone-facilitated detection. In this assay, mono-and oligosomes are captured on precoated DNA-binding proteins. Anti-histone 3 biotin-labeled antibody then binds to the histone component of captured nucleosomes and are detected following incubation with streptavidin-linked horseradish peroxidase conjugate. HRP catalyses the conversion of colorless tetramethylbenzidine to blue. The addition of stop solution changes the color to yellow, the intensity of which is proportional to the number of nucleosomes in the sample. Quantitation was carried out using ELISA through the construction of a standard curve. Absorbance was measured 
Comet assay
Cells were infected with either Ad-Survivin (T34A), Ad-Survivin-WT, or Ad-Survivin-Empty, as described above. The primary GBM cell lines were then treated by radiation (2 Gy) and subsequently evaluated for extent of double-strand DNA damage using the Comet (Single Cell Gel Electrophoresis) assay at various time points after radiation exposure (5 min to 96 h). Double-strand DNA breaks, which are known to be lethal events leading to radiation cell kill (Hall, 2000) , were evaluated using neutral lysis and electrophoresis. Single cells embedded in agarose were lysed to remove proteins and were then electrophoresed. Staining was performed with ethidium bromide, with quantitative image analysis of DNA image length and tail length, which has been found to be associated with the degree of double-strand DNA damage (Hall, 2000) .
ATP assay
ATP levels were evaluated using a commercially available ATP assay kit (Calbiochem). This assay utilized luciferase to catalyse the formation of light from ATP and luciferin, which was quantified using a luminometer. Primary GBM cells (10 3 cells) expressing either physiologic or supra-physiologic Survivin expression levels (via infection with Adeno-S(WT)) or dominant-negative Survivin (via infection with Adeno-S(T34A)) were irradiated (2 Gy). Corresponding cells that were not irradiated served as controls. Assessment of ATP levels was performed at various time points after irradiation to determine maximum ATP levels relative to unirradiated controls. At these time points, the culture media was removed and the cells were treated with 100 ml of Nuclear Releasing Agent for 5 min at room temperature. Then, 1 ml of ATP Monitoring Enzyme was added into the cell lysate. Luminometer readings were evaluated after 1 min.
